| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |